Coated-platelets in ischemic stroke: differences between lacunar and cortical stroke

J Thromb Haemost. 2008 Apr;6(4):609-14. doi: 10.1111/j.1538-7836.2008.02890.x. Epub 2008 Jan 8.

Abstract

Background: Coated-platelets are a subset of platelets with procoagulant potential observed upon dual agonist stimulation with collagen and thrombin.

Objective: The goal was to investigate if coated-platelet production differs between patients with lacunar ischemic stroke and non-lacunar (cortical) ischemic stroke as compared with controls.

Patients and methods: Blood samples from 60 patients with ischemic stroke (20 lacunar and 40 cortical) and 70 controls were analyzed for coated-platelet production.

Results: Coated-platelet production was significantly lower in patients with lacunar stroke (21.8 +/- 11.4%, mean +/- 1 SD) as compared with either controls (31.6 +/- 13.2%, P = 0.008) or patients with cortical stroke (39.4 +/- 12.7%, P < 0.001). The increase in coated-platelets for patients with cortical stroke as compared with controls was also significant (P = 0.008).

Conclusions: Our results indicate a marked difference in coated-platelet synthesis in lacunar vs. non-lacunar stroke, thereby providing additional support for the existence of distinct pathological processes underlying these two subtypes of ischemic stroke. Further investigation of the role of coated-platelets in stroke, taking into account these preliminary findings, is warranted.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Blood Coagulation Factors / analysis*
  • Blood Platelets / chemistry*
  • Blood Platelets / classification
  • Blood Platelets / drug effects
  • Brain Infarction / blood*
  • Brain Infarction / epidemiology
  • Brain Ischemia / blood*
  • Brain Ischemia / epidemiology
  • Collagen / pharmacology
  • Comorbidity
  • Drug Therapy, Combination
  • Drug Utilization
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Male
  • Middle Aged
  • Platelet Activation / drug effects
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Count
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Smoking / epidemiology
  • Thrombin / pharmacology

Substances

  • Blood Coagulation Factors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Serotonin Uptake Inhibitors
  • platelet procoagulant factor
  • Collagen
  • Thrombin